There is no licensed "microdosing" schedule for Mounjaro. The term is generally used to describe taking smaller, unmeasured amounts of the medicine than the licensed doses, sometimes by attempting to withdraw part of the medicine from a pen. This is different from the standard Mounjaro dosing schedule and is not a dosing approach recommended by the manufacturer.
Licensed Mounjaro treatment starts at 2.5 mg once a week, with dose increases made gradually when appropriate and under the direction of a prescriber. The licensed dosing schedule does not include a separate microdosing pathway below the starting dose.
If you are considering Mounjaro and are looking for a gentler start because you are concerned about side effects, or you are trying to manage the cost of treatment, it is better to discuss this with your prescriber. They can review your response and tolerability and decide whether your current dose should be continued or increased.
Why "Microdosing" Is Not a Licensed Mounjaro Treatment Timeline
Mounjaro is prescribed as a once weekly medicine, starting at 2.5 mg and increasing gradually when appropriate. The doses are defined as part of the licensed treatment schedule rather than being individually measured from a pen.
When people talk about a "Mounjaro microdosing chart" or a week by week microdosing plan online, they may be referring to one of two things:
- The normal process of starting Mounjaro at a lower licensed dose and increasing it gradually
- An unofficial practice of trying to extract smaller amounts from the pen
These are not the same thing. The second approach can make it difficult to know exactly how much medicine has been taken and may introduce risks associated with handling the medicine outside the manufacturer's instructions. For this reason, we do not recommend following unofficial microdosing charts or trying to create your own dose from a Mounjaro pen.
The licensed treatment schedule can be adjusted by a prescriber according to your response, side effects and individual circumstances, with doses increasing up to 15 mg once weekly where appropriate.
What Licensed Mounjaro Treatment May Look Like Week by Week
The first week or two. Your body is being introduced to tirzepatide for the first time. Some people experience gastrointestinal side effects such as nausea, diarrhoea, constipation or vomiting, while others notice few or no side effects. Appetite may also change during this early period, but individual experiences vary.
Weeks two to four. Some people find that early side effects become easier to manage as they continue with treatment, although this is not the case for everyone. Changes in appetite may also become more noticeable. If you have persistent or troublesome symptoms, speak to your prescriber rather than changing the dose yourself.
Around the one month mark. Your prescriber may review how you are responding to treatment, including any side effects and whether your current dose is appropriate. If a dose increase is suitable, this should be decided by your prescriber as part of your individual treatment plan rather than following a fixed timetable based on someone else's experience.
Beyond the first month. If treatment continues to be suitable, your weekly injection becomes part of your regular routine. Your dose may be increased gradually when appropriate, but not everyone needs to reach the highest available dose. Your prescriber will consider your response and how well you tolerate treatment when deciding what comes next.
Mounjaro is intended to be used alongside a reduced calorie diet and increased physical activity for weight management. The medicine is not intended to replace these lifestyle measures, and results can vary considerably between individuals.
This is a general guide rather than a prediction of what will happen to you. If you are considering a lower dose because of side effects, concerns about treatment or the cost of ongoing prescriptions, speak with your prescriber before making any changes to how you use Mounjaro.
Can Microdosing Be Used as a Maintenance Dose?
Some people ask whether taking very small, self measured amounts of Mounjaro could help maintain their goal weight or reduce the chance of weight regain. However, self measured microdosing is not a recognised or licensed maintenance approach.
There is not enough clinical evidence to establish the safety or effectiveness of taking Mounjaro below its licensed dosing range. Trying to extract and measure part of a dose can also make it difficult to know exactly how much medicine has been taken and may introduce risks such as contamination or incorrect dosing.
If you are looking for a lower long term dose or are concerned about the cost of treatment, speak to your prescriber. They can review your response, tolerability and treatment goals and discuss whether a licensed maintenance dose is appropriate for you. The right approach can differ from person to person, so it is better to agree on a plan with your healthcare professional than to create your own microdosing schedule.
The Real Risks and Side Effects, Briefly
Trying to extract Mounjaro from the pen using a separate syringe is different from using the device as intended. It can introduce a risk of contamination and makes accurate dosing more difficult because the pen is designed to deliver a specific dose rather than a manually measured fraction.
There is also a practical storage issue. Once a Mounjaro KwikPen is in use, it should be used within 30 days. Trying to divide doses over a longer period does not extend this recommended use period.
These risks are not removed by following a microdosing chart. A chart may help with calculations, but it cannot guarantee that the amount withdrawn is accurate or that the medicine remains suitable after being handled outside the manufacturer's instructions.
If you are concerned about the cost of treatment or how to manage your dose over the longer term, speak to your prescriber rather than trying to split doses yourself. For more information about Mounjaro treatment, including safe and licensed use, see our dedicated guide.
What to Do Instead
If you are considering microdosing because you are worried about side effects, the cost of treatment or starting at a gentler pace, these are all reasonable things to discuss with your prescriber.
Your prescriber can review how you are responding to treatment and whether you should remain on your current licensed dose, increase it gradually, or consider another appropriate treatment. They can also discuss practical ways to manage the ongoing cost of treatment.
If Mounjaro is not suitable for you or does not meet your treatment needs, your prescriber can discuss other prescription weight loss treatments and help you consider which option may be appropriate based on your health, treatment goals and individual circumstances.
The important point is that a lower dose should still be a measured, licensed dose agreed with your prescriber, rather than an unmeasured amount taken from a pen.